These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 19262224)

  • 1. The emerging role of high-density lipoprotein cholesterol in hypertension trials.
    Angeli F; Reboldi G; Gentile G; Verdecchia P
    J Hypertens; 2009 Mar; 27(3):458-60. PubMed ID: 19262224
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study.
    Olsen MH; Wachtell K; Beevers G; Dahlöf B; de Simone G; Devereux RB; de Faire U; Fyhrquist F; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Lyle PA; Nieminen MS; Omvik P; Oparil S; Wedel H
    J Hypertens; 2009 Mar; 27(3):567-74. PubMed ID: 19262226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, apoproteins and a case of a drug trial that did not fulfil expectations.
    Dominiczak MH
    Curr Opin Lipidol; 2007 Oct; 18(5):603-6. PubMed ID: 17885434
    [No Abstract]   [Full Text] [Related]  

  • 4. Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Assessment Project (L-TAP) 2.
    Santos RD; Waters DD; Tarasenko L; Messig M; Jukema JW; Ferrières J; Verdejo J; Chiang CW;
    Am Heart J; 2009 Nov; 158(5):860-6. PubMed ID: 19853709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotinic acid and the prevention of coronary artery disease.
    Digby JE; Lee JM; Choudhury RP
    Curr Opin Lipidol; 2009 Aug; 20(4):321-6. PubMed ID: 19494772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the incremental benefits of raising high-density lipoprotein cholesterol levels during lipid therapy after adjustment for the reductions in other blood lipid levels.
    Grover SA; Kaouache M; Joseph L; Barter P; Davignon J
    Arch Intern Med; 2009 Oct; 169(19):1775-80. PubMed ID: 19858435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term benefit of high-density lipoprotein cholesterol-raising therapy with bezafibrate: 16-year mortality follow-up of the bezafibrate infarction prevention trial.
    Goldenberg I; Boyko V; Tennenbaum A; Tanne D; Behar S; Guetta V
    Arch Intern Med; 2009 Mar; 169(5):508-14. PubMed ID: 19273782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Almonds have a neutral effect on serum lipid profiles: a meta-analysis of randomized trials.
    Phung OJ; Makanji SS; White CM; Coleman CI
    J Am Diet Assoc; 2009 May; 109(5):865-73. PubMed ID: 19394473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol with apolipoprotein B during simvastatin + fenofibrate therapy in patients with combined hyperlipidemia (a subanalysis of the SAFARI trial).
    Grundy SM; Vega GL; Tomassini JE; Tershakovec AM
    Am J Cardiol; 2009 Aug; 104(4):548-53. PubMed ID: 19660610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of increasing high-density lipoprotein cholesterol and decreasing low-density lipoprotein cholesterol on the incidence of first acute coronary events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study).
    Cui Y; Watson DJ; Girman CJ; Shapiro DR; Gotto AM; Hiserote P; Clearfield MB
    Am J Cardiol; 2009 Sep; 104(6):829-34. PubMed ID: 19733719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bibliography. Current world literature.
    Curr Opin Cardiol; 2006 Jul; 21(4):405-31. PubMed ID: 16755212
    [No Abstract]   [Full Text] [Related]  

  • 12. Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes.
    Patel S; Drew BG; Nakhla S; Duffy SJ; Murphy AJ; Barter PJ; Rye KA; Chin-Dusting J; Hoang A; Sviridov D; Celermajer DS; Kingwell BA
    J Am Coll Cardiol; 2009 Mar; 53(11):962-71. PubMed ID: 19281927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline characteristics of participants in the Hypertension in the Very Elderly Trial (HYVET).
    Bulpitt CJ; Beckett NS; Peters R; Banya W; Liu L; Wang JG; Stoyanovsky V; Dumitrascu D; Nikitin Y; Staessen JA; Burch L; Fletcher AE
    Blood Press; 2009; 18(1-2):17-22. PubMed ID: 19353407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of serum high-density lipoprotein cholesterol level as an independent predictor of one-year mortality after percutaneous coronary interventions.
    Ghazzal ZB; Dhawan SS; Sheikh A; Douglas JS; Veledar E; Mavromatis K; Pohlel FK; Vaccarino V
    Am J Cardiol; 2009 Apr; 103(7):902-6. PubMed ID: 19327413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Jekyll and Hyde of HDL: a lipoprotein with a split personality.
    Shah PK
    Eur Heart J; 2013 Dec; 34(46):3531-4. PubMed ID: 24062336
    [No Abstract]   [Full Text] [Related]  

  • 16. The Odyssey of Masked Hypertension in the HOMERUS Trial.
    Pierdomenico SD
    Am J Hypertens; 2007 Dec; 20(12):1266-7. PubMed ID: 18047915
    [No Abstract]   [Full Text] [Related]  

  • 17. Why HDL cholesterol is 'good cholesterol'.
    van der Giet M; Tölle M
    Eur J Clin Invest; 2004 Apr; 34(4):247-8. PubMed ID: 15086354
    [No Abstract]   [Full Text] [Related]  

  • 18. High-density lipoprotein as a therapeutic target: a peep into the future.
    Jain P
    Indian Heart J; 2006; 58(4):350-1. PubMed ID: 19039154
    [No Abstract]   [Full Text] [Related]  

  • 19. Statins and hypertension.
    Cífková R; Nilsson PM
    J Hypertens; 2009 Mar; 27(3):662-5. PubMed ID: 19262236
    [No Abstract]   [Full Text] [Related]  

  • 20. Impaired protection against diabetes and coronary heart disease by high-density lipoproteins in Turks.
    Onat A; Can G; Ayhan E; Kaya Z; Hergenç G
    Metabolism; 2009 Oct; 58(10):1393-9. PubMed ID: 19570555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.